LC-MS is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Saccharopine is an intermediate in the metabolism of amino acid lysine. It is a precursor of lysine in the alpha-aminoadipate pathway which occurs in fungi and euglenids. In mammals and seed plants saccharopine is an intermediate in the degradation of lysine, formed by condensation of lysine and alpha-ketoglutarate.
===== Southern Land Bridge project ===== Paetongtarn Shinawatra has adopted the 1-trillion-baht Southern Land Bridge project as a cornerstone of her administration's economic policy, positioning herself as its chief advocate and lead promoter on the international stage. Her role is multifaceted, encompassing policy direction, investment promotion, and stakeholder management for one of Thailand's most ambitious and controversial mega-projects. The project aims to construct a 90-kilometer logistics corridor, including deep-sea ports in Ranong (Andaman Sea) and Chumphon (Gulf of Thailand), linked by a motorway and dual-track railway. This would create a strategic alternative to the congested Strait of Malacca for maritime transport. She has argued that it will reduce shipping times by several days, lower costs by up to 15%, create an estimated 280,000 jobs, and boost GDP growth. During numerous overseas roadshows and at major domestic events like the "Ignite Thailand" forum in March 2025, she has presented the project as a key opportunity for investment. She has actively courted interest from global players, particularly during her official visit to China in February 2025, and has highlighted investment interest from firms in China, the Middle East (notably Dubai Port World), and financial institutions like the Asian Infrastructure Investment Bank (AIIB).
== Environmental benefits == Insects require significantly less feed, can be used in feed, and release fewer CO2 emissions than conventional animal food sources. They can be used to address the issue of depleted agricultural lands as they do not need much space to be reared as compared to livestock. Insects may be a sustainable commercial farming option to support populations struggling with food security due to their nutrition and farming capacities, taking less room to cultivate than other protein sources. Additionally, since insects can eat food waste, and they require less feed, they are a good option to address food waste. However, insect consumption remains less sustainable overall than plant-based food, and insects are often used as feed for aquaculture and livestock rather than for direct human consumption.
=== Diet === The coastal taipan's diet consists predominantly of rats, mice, and bandicoots, with various species of birds taken opportunistically. In 2010, a dead coastal taipan was found to have ingested a cane toad. Whether the snake had been poisoned by the toad and died, or had resisted the poison and been killed by a vehicle (as it was found on a road with neck trauma) was unknown. When hunting, it appears to actively scan for prey using its well-developed eyesight, and is often seen traveling with its head raised slightly above ground level. Once prey is detected, the snake "freezes" before hurling itself forward and issuing several quick bites. The prey is released and allowed to stagger away. This strategy minimises the snake's chance of being harmed in retaliation, particularly by rats, which can inflict lethal damage with their long incisors and claws. The coastal taipan closely resembles the African black mamba (Dendroaspis polylepis) in body shape, venom toxicity, and hunting behaviour—both employing a "snap and release" strategy. This convergence is thought due to their adaptation to hunting mammals; the large size is needed to eat large prey, and lethal venom is to immobilise prey quickly before they can damage the predator.
==== Supranational ==== United Nations: UN Assistance Mission in Afghanistan (UNAMA) urged both nations to cease hostilities and to take steps to prevent harm to civilians. Richard Bennett, the UN Special Rapporteur on the situation of human rights in Afghanistan, expressed concern over airstrikes in Nangarhar and Paktika, calling on the belligerent parties to exercise "maximum restraint". He stated deep concern for "a significant number of children and civilians" who were killed following the hostilities. European Union: In a brief statement, the EU Council called on all actors for immediate de-escalation and a halt of hostilities in the area. It reiterated to the Taliban that Afghan territory must not be used to threaten or attack other countries and calls on them to take effective action against all terrorist groups operating in or from Afghanistan.
Sources: en.wikipedia.org
Adenine and guanine are the two nitrogenous bases classified as purines. In purine synthesis, phosphoribosyl pyrophosphate (PRPP) is converted into inosine monophosphate (IMP). The production of IMP from PRPP requires glutamine, glycine, aspartate, and six molecules of adenosine triphosphate (ATP), among other components. IMP serves as a precursor for both adenosine monophosphate (AMP) and guanosine monophosphate (GMP). AMP is synthesized from IMP using guanosine triphosphate (GTP) and aspartate, with aspartate being converted into fumarate. In contrast, the synthesis of GMP requires an intermediate step: IMP is first oxidized by NAD⁺ to form xanthosine monophosphate (XMP), which is subsequently converted into GMP via the hydrolysis of one ATP molecule and the conversion of glutamine to glutamate. Both AMP and GMP can be phosphorylated by kinases to form adenosine triphosphate (ATP) and guanosine triphosphate (GTP), respectively. ATP stimulates the production of GTP, while GTP stimulates the production of ATP. This cross-regulation maintains a balanced ratio of ATP and GTP, preventing an excess of either nucleotide, which could increase the risk of DNA replication errors and purine misincorporation. Lesch–Nyhan syndrome is caused by a deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), an enzyme that catalyzes the salvage of guanine to GMP. This X-linked congenital disorder leads to the overproduction of uric acid and is associated with neurological symptoms, including intellectual disability, spasticity, and compulsive self-mutilation.
The "Cave of the Sixteen sword bearers" ("Höhle der Schwertträger", 十六带剑者窟) is a famous cave with a series of murals showing swordsmen wearing caftans and armed with long sword and daggers. These murals have been carbon dated to 432–538 CE. The swordsmen have also been dubbed the "Tocharian donors". The interpretations of the nationality or ethnicity of the donors have varied. Some authors claim that the donors are indeed Tocharians, an elusive people of the Tarim Basin who spoke the well-documented Tocharian language, the easternmost Indo-European language. According to this thesis, the donors in the murals are of the Indo-European type, wearing Iranian-style clothes and reddish hair. A more recent interpretation is that the sword-bearers are actually Hephthalites, who are known to have occupied the Tarim Basin from 490 to 560 CE, precisely at the time the paintings were made. Kucha was specifically part of their dominion between 502 and 556 CE. The clothing style, the iconography and the physiognomy of the donors are said to be extremely close to those depicted in the paintings of Tokharistan (Bactria), the center of Hephthalite power, at sites such as Balalyk tepe or Dilberjin Tepe. In particular, the coat with single folded lapel is considered as a result of Hephthalite influence, whereas traditional Kuchean coats had two lapels. At present, the most prevalent opinion among academics seems to be that the Hephthalites were initially of Turkic origin. Similar donors can be seen in the Kumtura Caves.
IUPAC definition "secular equilibrium", IUPAC definition (IUPAC Compendium of Chemical Terminology 2nd Edition, 1997) (in English) Radioactive Equilibrium, EPA definition Radioactive Equilibrium. An equilibrium as old as the Earth Archived 2019-07-28 at the Wayback Machine, radioactivity.eu.com, IN2P3, EDP Science
=== Synthetic transcription factors === Studies have considered the components of the DNA transcription mechanism. One desire of scientists creating synthetic biological circuits is to be able to control the transcription of synthetic DNA in unicellular organisms (prokaryotes) and in multicellular organisms (eukaryotes). One study tested the adjustability of synthetic transcription factors (sTFs) in areas of transcription output and cooperative ability among multiple transcription factor complexes. Researchers were able to mutate functional regions called zinc fingers, the DNA specific component of sTFs, to decrease their affinity for specific operator DNA sequence sites, and thus decrease the associated site-specific activity of the sTF (usually transcriptional regulation). They further used the zinc fingers as components of complex-forming sTFs, which are the eukaryotic translation mechanisms.
Sources: en.wikipedia.org
== Honors and awards == 1981–1982: Fogarty International Scholar 1981: Honorary Member of the American Society of Biological Chemistry 1984: Rothschild Prize in Chemistry 1987: Wolf Prize in Medicine, jointly with Pedro Cuatrecasas, "for the invention and development of affinity chromatography and its applications to biomedical sciences." 1987: Pierce Prize for Biorecognition Technology 1988: Elected Member of the Israel Academy of Sciences and Humanities 1989: Doctor of Science, honoris causa, University of Waterloo, Canada 1989: Barnett Lecturer, Northeastern University, Boston 1990: Israel Prize, in life sciences 1990: Sarstedt Prize (Numbrecht, Germany) 1993: Foreign Associate Member, Institute of Medicine, National Academy of Science, USA 1995: Doctor of Science, honoris causa, Bar Ilan University, Israel 1996: International Distinguished Clinical Chemist Award, International Federation of Clinical Chemistry (IFCC) 2000: Doctor of Science, honoris causa, University Jyvaskyla, Finland 2000: Honorary Doctorate, Ben-Gurion University of the Negev 2002: Honorary Citizen, City of Rehovot, Israel 2004: Wilhelm Exner Medal. 2004: Christian B. Anfinsen Award of The Protein Society 2004: Wilhelm-Exner Medal, OGV, President of Austria 2005: Emet Prize, presented by the Prime Minister of Israel
== Pharmacological targets == Recombinant forms of human relaxin-2 such as volenrelaxin (LY3540378) and serelaxin (RLX030) have been developed as investigational drugs. It is suggested that relaxin could be used as a therapeutic target when it comes to gynaecological disorders.
It also made US economic and military aid, including arms sales, dependent on countries aligning with US anti-drug policies. Later, the terms "major illicit drug-producing country" and "major drug-transit country" were defined in the act; as of 1986, the president has been required to annually determine which countries fit those definitions. Those not adequately cooperating with counter-drug efforts would not be eligible to receive US financial aid, although the president could and has provided waivers to individual countries. The so-called "majors list" has influenced how US assistance money is used internationally in the war on drugs, although in recent years, it has remained relatively static and lost a degree of relevancy. In September 2023, President Biden added China to the majors list, citing its production of precursor chemicals. Foreign anti-drug initiatives initially focused on Latin America, and expanded globally over time. Since the 1970s, billions of US aid dollars have been directed to anti-drug activity in Latin America. The US initially treated drug control as a law enforcement issue in foreign countries, providing assistance to police forces. In the 1980s, the US increasingly involved the military and private security firms, to provide training and support to armed forces in drug-producing and transit countries. As of 2024, the DEA has, in addition to 241 domestic offices, 93 foreign offices in 69 countries.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.